Madrigal Pharmaceuticals (MDGL) Change in Intangibles (2024 - 2025)
Madrigal Pharmaceuticals (MDGL) reported Change in Intangibles of $3.0 million for Q3 2025, down 40.0% quarter-over-quarter from $5.0 million in Q2 2024.
Madrigal Pharmaceuticals (MDGL) Change in Intangibles (2024 - 2025) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 2 years of Change in Intangibles data on file, last reported at $3.0 million in Q3 2025.
- Change in Intangibles for Q3 2025 came in at $3.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $3.0 million (down 40.0% YoY), and the FY2025 annual result was $3.0 million, down 40.0% from the prior year.
- Change in Intangibles retreated to $3.0 million in Q3 2025 per MDGL's latest filing, from $5.0 million in the prior quarter.
- Over five years, Change in Intangibles peaked at $5.0 million in Q2 2024 and troughed at $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Madrigal Pharmaceuticals | 14.67 Bn | 14.44 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 5.00 Mn |